Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 48 matching records.
48 results — page 1 of 2
- Level DLaboratory StudyEurope PMC
The Interplay Between Neuromodulation and Stem Cell Therapy for Sensory-Motor Neuroplasticity After Spinal Cord Injury: A Perspective View
Laboratory Study on Spinal Cord Injury, Scar, published in J Clin Med (2026) — summary generated from the PubMed abstract.
- 2026
J Clin Med1 citations - Level BClinical TrialEurope PMC
Cell therapy for stroke and spinal cord injury in clinical trials
Clinical Trial on Stroke Research, Spinal Cord Injury, published in Stem Cells Transl Med (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cells Transl Med1 citations - Level ASystematic ReviewPubMed
Host immune determinants of stromal vascular fraction graft survival: Toward a concept of SVF therapy resistance - A systematic narrative review.
Systematic Review on Spinal Cord Injury, Chronic Inflammation, Immune Modulation, published in Cell Transplant (2026) — summary generated from the PubMed abstract.
- 2026
Cell Transplant - Level CCase Report / SeriesPubMed
Spinal epidural lipomatosis in pediatric medulloblastoma following chemotherapy, a case report and review of the literature.
Case Report / Series on Back & Spine, Systemic / IV, published in Childs Nerv Syst (2025) — summary generated from the PubMed abstract.
- 2025
Childs Nerv Syst - Level CCohort StudyPubMed
Autophagy modulation by hADSCs and green light therapy alleviates inflammation and promotes functional recovery after spinal cord injury.
Cohort Study on Spinal Cord Injury, Neuroinflammation, Scar, Chronic Inflammation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther1 citations - Level DNarrative ReviewEurope PMC
Exploring the Emerging Role of Stem Cell Therapy in Neurodegenerative Diseases and Spinal Cord Injury: A Narrative Review
Narrative Review on Spinal Cord Injury, Neuroinflammation, Immune Modulation, published in Cureus (2025) — summary generated from the PubMed abstract.
- 2025
Cureus1 citations - Level CProspective StudyPubMed
Dysfunctional vasculogenesis in adipose-derived stem cells from chronic spinal cord injury patients: implications for autologous cell therapy.
Prospective Study on Spinal Cord Injury, Chronic Wound, published in Angiogenesis (2025) — summary generated from the PubMed abstract.
- 2025
Angiogenesis - Level ASystematic ReviewEurope PMC
Insights into Astrogliosis, Inflammation Processes, and Emerging Treatments by Exosome Therapy and Low-Level Laser Therapy for Spinal Cord Injury: A Systematic Review
Systematic Review on Spinal Cord Injury, Neuroinflammation, published in J Lasers Med Sci (2025) — summary generated from the PubMed abstract.
- 2025
J Lasers Med Sci - Level BClinical TrialPubMed
Adipose-derived stem cell therapy for spinal cord injuries: Advances, challenges, and future directions.
Clinical Trial on Spinal Cord Injury, published in Regen Ther (2024) — summary generated from the PubMed abstract.
- 2024
Regen Ther11 citations - Level BClinical TrialPubMed
Adipose-Derived Stem Cell Therapy in Spinal Cord Injury.
Clinical Trial on Spinal Cord Injury, published in Cells (2024) — summary generated from the PubMed abstract.
- 2024
Cells5 citations - Level DAnimal StudyEurope PMC
Injectable alginate chitosan hydrogel as a promising bioengineered therapy for acute spinal cord injury
Animal Study on Cardiovascular Disease, Spinal Cord Injury, Scar, published in Sci Rep (2024) — summary generated from the PubMed abstract.
- 2024
Sci Rep7 citations - Level DLaboratory StudyPubMed
Combination of Adult Mesenchymal Stem Cell Therapy and Immunomodulation with Dimethyl Fumarate Following Spinal Cord Ventral Root Repair.
Laboratory Study on Spinal Cord Injury, Chronic Inflammation, Immune Modulation, published in Biology (Basel) (2024) — summary generated from the PubMed abstract.
- 2024
Biology (Basel) - Level DNarrative ReviewEurope PMC
Neurotrophic Factors as Regenerative Therapy for Neurodegenerative Diseases: Current Status, Challenges and Future Perspectives
Narrative Review on Spinal Cord Injury, Neuroinflammation, published in Int J Mol Sci (2023) — summary generated from the PubMed abstract.
- 2023
Int J Mol Sci56 citations - Level AMeta-analysisPubMed
Mesenchymal stem cell-derived extracellular vesicles therapy in traumatic central nervous system diseases: a systematic review and meta-analysis.
Meta-analysis with a reported sample of 52 on Spinal Cord Injury, published in Neural Regen Res (2023) — summary generated from the PubMed abstract.
- 2023
- n = 52
Neural Regen Res - Level ASystematic ReviewEurope PMC
Mesenchymal Stem Cell Therapy in Traumatic Spinal Cord Injury: A Systematic Review
Systematic Review on Spinal Cord Injury, published in Int J Mol Sci (2023) — summary generated from the PubMed abstract.
- 2023
Int J Mol Sci35 citations - Level DNarrative ReviewEurope PMC
Salvianolic Acid B: A Review of Pharmacological Effects, Safety, Combination Therapy, New Dosage Forms, and Novel Drug Delivery Routes
Narrative Review on Spinal Cord Injury, Chronic Inflammation, published in Pharmaceutics (2023) — summary generated from the PubMed abstract.
- 2023
Pharmaceutics69 citations - Level AMeta-analysisPubMed
Stem cell-derived exosomes for traumatic spinal cord injury: a systematic review and network meta-analysis based on a rat model.
Meta-analysis on Spinal Cord Injury, published in Cytotherapy (2023) — summary generated from the PubMed abstract.
- 2023
Cytotherapy - Level DNarrative ReviewEurope PMC
An Insight into the Prospects and Drawbacks of Stem Cell Therapy for Spinal Cord Injuries: Ongoing Trials and Future Directions
Narrative Review with a reported sample of 80 on Spinal Cord Injury, Immune Modulation, published in Brain Sci (2023) — summary generated from the PubMed abstract.
- 2023
- n = 80
Brain Sci13 citations - Level DNarrative ReviewEurope PMC
Regenerative Rehabilitation and Stem Cell Therapy Targeting Chronic Spinal Cord Injury: A Review of Preclinical Studies
Narrative Review on Spinal Cord Injury, published in Cells (2022) — summary generated from the PubMed abstract.
- 2022
Cells32 citations - Level DNarrative ReviewEurope PMC
Electroactive Scaffolds to Improve Neural Stem Cell Therapy for Spinal Cord Injury
Narrative Review with a reported sample of 80 on Spinal Cord Injury, published in Front Med Technol (2022) — summary generated from the PubMed abstract.
- 2022
- n = 80
Front Med Technol16 citations - Level BClinical TrialPubMed
Stem cell-based therapy for human diseases.
Clinical Trial on Spinal Cord Injury, Burns, published in Signal Transduct Target Ther (2022) — summary generated from the PubMed abstract.
- 2022
Signal Transduct Target Ther747 citations - Level DAnimal StudyPubMed
Synergic Effect of Combined Therapy of Hyperbaric Oxygen and Adipose-Derived Mesenchymal Stem Cells on Improving Locomotor Recovery After Acute Traumatic Spinal Cord Injury in Rat Mainly Through Downregulating Inflammato
Animal Study on Spinal Cord Injury, published in Cell Transplant (2022) — summary generated from the PubMed abstract.
- 2022
Cell Transplant5 citations - Level BClinical TrialPubMed
Stem Cell Therapy for Spinal Cord Injury.
Clinical Trial on Spinal Cord Injury, Immune Modulation, published in Cell Transplant (2021) — summary generated from the PubMed abstract.
- 2021
Cell Transplant105 citations - Level BClinical TrialEurope PMC
Review of operative considerations in spinal cord stem cell therapy
Clinical Trial on Spinal Cord Injury, published in World J Stem Cells (2021) — summary generated from the PubMed abstract.
- 2021
World J Stem Cells9 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406